Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis
By G. Millonig, Frank Reimann, S. Friedrich, H. Fonouni, A. Mehrabi, M. Büchler, H. Seitz, S. Mueller. Hepatology, 2008
622 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/856bcd9fb6caf05e4ada229df099fcb42b8ee46e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- Asociacion Latinoamericana para el Estudio del Higado
- C. Day
- S. Bellentani
- V. Ratziu
- H. Cortez‐Pinto
- Laurent Castéra
- M. Kudo
- Giulio Marchesini
In Hepatology
- Asociacion Latinoamericana para el Estudio del Higado
- M. Kudo
- C. Day
- F. Piscaglia
- S. Bellentani
- Laurent Castéra
- A. Berzigotti
Citations in the corpus
- WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver. (2015, background): “extrahepatic cholestasis (Millonig et al. 2008) or congestive heart failure (Millonig et al.”
- EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version) (2017, background): “Liver stiffness is increased with hepatic inflammation (often but not exclusively shown by an elevated transaminase level) [41 – 44], obstructive cholestasis [45] and hepatic congestion [46, 47].”
- Easl Clinical Practice Guidelines (Cpgs) On Non-Invasive Tests For Evaluation Of Liver Disease Severity And Prognosis- 2020 Update. (2021, background): “In patients with increased serum bilirubin due to the presence of a high-grade stenosis in the extrahepatic bile ducts, LS values need to be carefully interpreted due to the relevant risk of over-estimation of the fibrosis stage [204-206].”
- A position statement on NAFLD/NASH based on the EASL 2009 special conference. (2010, background): “Journal of Hepatology 201 healthy individuals without the metabolic syndrome can be as high as 8 kPa [122], and increased liver stiffness can be seen without fibrosis in different conditions [123–125].”
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. (2015, background): “However, untreated dominant stricture of the common bile duct or primary hepatic ducts should be ruled out in PSC patients since obstructive cholestasis influences LS assessment [72].”